ARCHIVES

Two Phase II Studies of Ibrutinib Deliver High Response Rates

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

NCAB Committee Seeks Organ Systems Upgrade

February 7, 1986

NIH Authorization Bills Require NCI To Spend 10% On Cancer control

February 12, 1993

GAO Report On NCI Cancer Control Contracts (Continued)

August 1, 1980

In Brief: Search Narrows ACS Head; Selections For Breast Cancer Commission Still At HHS

March 27, 1992

In Brief: Jane Henney Sworn In As FDA Commissioner; Six Centers Retain Comprehensive Status

December 18, 1998

Firm Reports Limited Market For Self-Test Detection Methods

July 29, 1983